Treatment strategies for rituximab-resistant primary membranous nephropathy: from resistance mechanisms to emerging therapies - Summary - MDSpire

Treatment strategies for rituximab-resistant primary membranous nephropathy: from resistance mechanisms to emerging therapies

  • By

  • Jingjie Gao

  • Yanan Pei

  • Lijuan Wei

  • Bo Yang

  • Hongtao Yang

  • June 11, 2026

  • 0 min

Share

Objective:

Emphasize the significance of understanding resistance mechanisms.

Key Findings:
  • Add genetic susceptibility as a resistance factor.
Interpretation:

Elaborate on implementation of individualized treatment approaches.

Limitations:
  • Include a mention of the need for comprehensive studies on resistance mechanisms.
Conclusion:

Reiterate the importance of ongoing research.

Original Source(s)

Treatment strategies for rituximab-resistant primary membranous nephropathy: from resistance mechanisms to emerging therapies

  • by Jingjie Gao, Yanan Pei, Lijuan Wei, Bo Yang, Hongtao Yang

  • June 11, 2026

Related Content

Serum complement system activation in normal healing and atrophic non-union of human long bone fractures

Therapeutic scarification, shadow pain, and integrative geriatric rehabilitation for chronic musculoskeletal pain in older adults in Cameroon: a prospective mixed-methods observational study

Lower BMI, Lower Joint Replacement Risk?

Researchers urge caution in interpreting joint replacement predictors, noting that surgery reflects access and decision-making as well as disease biology.